Add BrightSurf on Google Email

Harm from missing incidents among people with dementia

A new analysis of police data reveals that one in 10 missing incidents among people with dementia results in serious harm. The study highlights the need for preventative action to keep people with dementia safe and finds that older age, night disappearances, and longer durations of absence are risk factors for harm.

SourceUniversity College London·JournalAge and Ageing·TypeMeta-analysis·DateMay 12, 2026

Cardiovascular and metabolic diseases are primary drivers of excess US deaths compared to other high-income countries

The US had substantially higher death rates between 1999 and 2022 compared to other wealthy nations, with cardiovascular diseases being the leading cause of excess mortality. An estimated 12.7 million US deaths could have been averted during this period if US mortality rates mirrored those of its peers.

SourceBoston University School of Public Health·JournalJAMA Network Open·TypeObservational study·DateMay 8, 2026

Housing insecurity, incident geriatric conditions, and mortality in community-living older persons

A cohort study found that poor housing affordability was associated with higher risks of frailty, disability, dementia, and mortality, while poor housing quality was linked to increased risks of frailty, disability, and mortality. Housing insecurity is identified as a clinically relevant social determinant of health among older persons.

SourceJAMA Network·JournalJAMA Network Open·DateMay 1, 2026

Half of older patients with dementia remain on psychotropic drugs a year after starting on them

A recent study published in JAMA Network Open found that half of older patients with dementia remain on psychotropic drugs a year after starting them. The medications, including antipsychotics and benzodiazepines, are often prescribed in acute and post-acute settings such as emergency rooms and skilled nursing facilities. This raises c...

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeData/statistical analysis·DateApr 28, 2026

Digital reminiscence app could reduce grief and improve relationships between dementia patients and caregivers

A web tool called Living Memory Home for Dementia Care Pairs facilitates collaborative reminiscence therapy, reducing feelings of pre-death grief and improving relationship quality. The app promotes well-being and connection between dementia patients and caregivers, leading to better care outcomes.

SourceUniversity of Southern California·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateApr 22, 2026

Mini brain-like structures grown in lab may help scientists treat, diagnose and stage Alzheimer’s disease

Researchers from Johns Hopkins Medicine have developed mini brain-like structures grown in the lab that could be used to evaluate how patients with Alzheimer's disease respond to certain drugs. The study found that tiny particles secreted by these brain tissues may contain cellular information that could help scientists find new biomar...

SourceJohns Hopkins Medicine·JournalAlzheimer’s & Dementia·DateApr 20, 2026

Anti-amyloid Alzheimer’s drugs show no clinically meaningful effect

A new Cochrane review of 17 clinical trials found that anti-amyloid Alzheimer's drugs have no significant impact on cognitive decline or dementia severity, but may increase the risk of brain swelling and bleeding. The evidence suggests that these drugs are unlikely to provide clear benefit to patients.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateApr 15, 2026

Scientists reverse brain aging, with a nasal spray

Researchers developed a nasal spray that reversibly reduces brain inflammation, restores cellular power plants, and improves memory. The treatment bypasses the brain's protective shield through intranasal delivery, suppressing chronic inflammation and promoting successful brain aging.

SourceTexas A&M University·JournalJournal of Extracellular Vesicles·DateApr 14, 2026

Confirming the potential to treat dementia with FDA-approved drugs DGIST discovers treatment mechanism to calm brain immune cells

A research team at DGIST has discovered a mechanism to treat dementia by regulating brain immune cells. Somatostatin, a neurotransmitter, prevents the overactivation of immune cells and restores their protective role in removing waste from the brain.

SourceDGIST (Daegu Gyeongbuk Institute of Science and Technology)·JournalBrain Behavior and Immunity·DateApr 9, 2026

Physical activity and appropriate sleep linked to subsequent lower dementia risk

A meta-analysis of millions of community-dwelling adults found that regular physical activity, less sedentary time, and appropriate nightly sleep (7-8 hours) were associated with a lower subsequent risk of dementia. Conversely, too little or too much sleep was linked to an increased risk, highlighting the importance of optimal sleep du...

SourcePLOS·JournalPLOS One·TypeMeta-analysis·DateApr 8, 2026

Can optimism protect against dementia?

A recent study published in Journal of the American Geriatrics Society found that individuals with higher optimism have a lower risk of developing dementia. After analyzing data from the Health and Retirement Study, researchers discovered a 15% lower risk associated with a one-standard-deviation increase in optimism.

SourceWiley·JournalJournal of the American Geriatrics Society·DateApr 8, 2026

People who can’t afford dental care may be at higher risk of developing cardiovascular disease, dementia

A new study found that older people who forego necessary dental procedures due to financial barriers may experience heart failure, a heart attack, a stroke, or dementia. The researchers suggest that alleviating upstream factors such as financial constraints could prevent chronic disease.

SourceBoston University School of Public Health·JournalThe Journals of Gerontology Series A·TypeObservational study·DateApr 1, 2026

Severe infections may raise dementia risk, study finds

A Finnish registry study found that severe infections, such as cystitis and bacterial disease, are associated with an increased risk of dementia. The study examined nationwide health registry data and identified 29 diseases linked to dementia risk, including mental disorders, Parkinson's disease, and alcohol-related mental disorders.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateMar 24, 2026

High meat consumption linked to lower dementia risk in genetic risk group

A new study from Karolinska Institutet found that older people with a genetic risk of Alzheimer's disease who consume relatively large amounts of meat have a lower risk of cognitive decline and dementia. The study also shows that the type of meat is important, with a lower proportion of processed meat associated with a lower risk of de...

SourceKarolinska Institutet·JournalJAMA Network Open·TypeObservational study·DateMar 19, 2026

Meat consumption and cognitive health by APOE genotype

A new study published in JAMA Network Open suggests that high meat consumption is associated with better cognitive trajectories and lower dementia risk among individuals with the APOE 34/44 genotype. The finding contradicts previous expectations, highlighting potential clinical and public health relevance for this population.

SourceJAMA Network·JournalJAMA Network Open·DateMar 19, 2026

New research shows how to diagnose people with Alzheimer’s plus a hard-to-identify dementia type

Researchers found that patients with both conditions exhibited different neuropsychiatric symptoms, which could inform diagnosis and treatment plans. The study's findings may help clinicians better understand the complex disease course of patients with multiple disorders, including Alzheimer's and frontotemporal lobar degeneration.

SourceBrown University·JournalNeurology·TypeData/statistical analysis·DateMar 16, 2026

USC study reveals differences in early Alzheimer’s brain markers across diverse populations

Researchers at USC identified differences in early Alzheimer's disease-related brain changes across racial and ethnic groups, with Black and Hispanic participants showing higher levels of tau in key memory-related regions. The study highlights the need for more inclusive approaches to studying and diagnosing Alzheimer's disease.

SourceKeck School of Medicine of USC·JournalAlzheimer s & Dementia·TypeData/statistical analysis·DateMar 12, 2026